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Abstract
Sequencing techniques have been widely used to assess gene expression (i.e., RNA-seq) or the 
presence of epigenetic features (e.g., DNase-seq to identify open chromatin regions). In contrast to 
traditional microarray platforms, sequencing data are typically summarized in the form of discrete 
counts, and they are able to delineate allele-specific signals, which are not available from 
microarrays. The presence of epigenetic features are often associated with gene expression, both 
of which have been shown to be affected by DNA polymorphisms. However, joint models with the 
flexibility to assess interactions between gene expression, epigenetic features and DNA 
polymorphisms are currently lacking. In this paper, we develop a statistical model to assess the 
associations between gene expression and epigenetic features using sequencing data, while 
explicitly modeling the effects of DNA polymorphisms in either an allele-specific or nonallele-
specific manner. We show that in doing so we provide the flexibility to detect associations between 
gene expression and epigenetic features, as well as conditional associations given DNA 
polymorphisms. We evaluate the performance of our method using simulations and apply our 
method to study the association between gene expression and the presence of DNase I 
Hypersensitive sites (DHSs) in HapMap individuals. Our model can be generalized to exploring 
the relationships between DNA polymorphisms and any two types of sequencing experiments, a 
useful feature as the variety of sequencing experiments continue to expand.
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1. Introduction
Gene expression regulation is an essential biological process by which static genetic 
information gives rise to dynamic organismal phenotypes [Jaenisch and Bird (2003)]. 
Multiple epigenetic features are involved in gene expression regulation, including DNase I 
hypersensitive sites (DHSs) [Song et al. (2011)], DNA methylation [Fang et al. (2012)] and 
histone modifications [Heintzman et al. (2009)]. DHSs, which delineate open chromatin 
regions, are among the most well-studied epigenetic features. DHSs often harbor regulatory 
DNA elements that can influence gene expression [Thurman et al. (2012)], and thus the 
presence or absence of DHSs is often associated with gene expression variation [Djebali et 
al. (2012)]. Both gene expression and DHSs are heritable [McDaniell et al. (2010)], and 
previous studies have found their variations are often associated with DNA variants such as 
single nucleotide polymorphisms (SNPs) [Degner et al. (2012), Pickrell et al. (2010)]. 
Characterizing these associations plays an important role in understanding how one’s 
genotype modifies phenotype, such as in Cowper-Sal et al. (2012), where the authors 
systematically determined SNPs associated with breast cancer and found these SNPs are 
over-represented on the binding sites of a transcription factor FOXA1. They then confirmed 
that these SNPs modified the FOXA1 binding strength, which further leads to imbalance of 
downstream gene regulation.
Gene expression and epigenetic features are being routinely assessed by high-throughput 
sequencing solutions, and the results are quantified by the number of sequenced reads within 
certain genomic regions. For example, the number of RNA-seq reads within a gene provides 
a measure of gene expression, which can be further normalized by read depth (the total 
number of sequencing reads sampled per individual) and gene length to facilitate 
comparison across individuals and across genes. Sequencing data not only provide more 
comprehensive and more accurate assessments of genomic activity, but also reveal novel 
information that is not available from traditional microarrays, such as allele-specific signals. 
In a diploid genome, the DNA sequence at each autosomal locus has two copies (i.e., the 
maternal and paternal copy), and each copy is referred to as an allele.
Recently, allele-specific signals have been studied in various sequencing studies, including 
gene expression [Pickrell et al. (2010)], DNA methylation [Fang et al. (2012)], transcription 
factor binding [Rozowsky et al. (2011)] and chromatin accessibility [Degner et al. (2012)]. 
Such allele-specific signals can be used to distinguish cis-acting and trans-acting genetic 
effects [Sun (2012)]. A cis-acting DNA polymorphism only modifies expression of genes or 
epigenetic features that are located on the same haploid genome as the DNA polymorphism. 
In contrast, a trans-acting DNA polymorphism has the same effect on both alleles of its 
target. Therefore, an imbalance of Allele-Specific Read Counts (ASReCs) of the two alleles 
within one individual implies the presence of a cis-acting regulatory element, and the 
variation of the Total Read Count (TReC, summation of read count from either allele) across 
individuals can be due to either cis-acting or trans-acting regulations.
Previous studies have demonstrated the association between gene expression and epigenetic 
features using either TReC or ASReC and their associations with DNA polymorphisms. 
Unfortunately, no study has systematically assessed the joint associations between gene 
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expression, epigenetic features and underlying genotype. Furthermore, no method exists to 
determine such associations with allele-specific sequencing data (ASReC). To address this 
issue, we develop a novel statistical method, which we refer to as BASeG (Bivariate 
Aassociation studies using Sequencing data, while accounting for shared Genetic effects). 
Specifically, we study the association of TReC and ASReC using Bivariate Poisson-Log-
Normal (BPLN) regression and Bivariate Binomial-Logistic-Normal (BBLN) regression, 
respectively. We demonstrate BASeG’s utility in simulations and a study of the association 
between gene expression (measured by RNA-seq) and DHSs (measured by DNase-seq). 
BASeG is general enough to be applied to study the associations between any two types of 
sequencing data, such as gene expression (by RNA-seq) vs. DNA methylation measured by 
bisulfite sequencing or histone modifications measured by ChIP-seq (Chromatin 
Immunoprecipitation followed by sequencing).
2. Model
2.1. Bivariate Poisson-log-normal regression for Total Read Count (TReC)
Assume we are interested in the RNA-seq TReC of a particular gene, denoted by TR, and the 
DNase-seq TReC within a particular genomic region (e.g., a 250-bp window in the promoter 
of the gene of interest), denoted by TC in the ith sample. For notational simplicity, we drop 
sample subscript i for now. We assume the expected value of TR is associated with a genetic 
variable ZR and some other covariates XR, and, similarly, the expected value of TC is 
associated with a genetic variable ZC and some other covariates XC. Such covariates may 
include the log of the sequencing depth for each sample (the log transformation is due to the 
fact that our model of TReC has a log link function), as well as demographic variables 
and/or batch effects. We also assume the genetic effect is additive such that ZR or ZC equals 
0, 1 or 2, which is the number of nonreference (alternative) alleles of the SNP. In this study, 
the reference allele of a SNP is defined based on the 1000 Genomes Project SNP annotation 
file and this definition is applied consistently across samples. Without loss of generality, we 
also assume that this genetic effect jointly impacts each data type (i.e., gene expression or 
DHSs), allowing us to assess whether the observed correlation of gene expression and DHSs 
is due to a joint effect of a single SNP. It is straightforward to define other types of genetic 
effects (e.g., dominant or co-dominant) if desired. We model the joint distribution of TR and 
TC by a bivariate Poisson-log-normal (BPLN) distribution:
(2.1)
where fP(;μ) denotes the Poisson distribution probability mass function with mean μ. For 
RNA-seq and DNase-seq data, we assume log(μR) = XRβR + ZRbR + εR and log(μC) = XCβC 
+ZCbC +εC, respectively, where εR and εC are two random variables following a bivariate 
normal distribution with mean 0 and covariance Σ1, denoted by the bivariate normal 
probability density function ϕ(εR, εC; Σ1),
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and −1 ≤ ρ1 ≤ 1 is a correlation parameter. Therefore, in this BPLN distribution, the 
correlation, in the absence of a shared genetic effect, between TR and TC is induced by the 
correlation ρ1 between εR and εC. We compare our model with that of a generalized mixed 
linear model framework with heterogeneous variances in the discussion section of this 
manuscript.
The probability mass function of (TR,TC) is obtained by integrating out the random effects 
εR and εC. To efficiently approximate this integral computationally, we utilize a multivariate 
form of adaptive Gauss-Hermite quadrature [Liu and Pierce (1994)]:
(2.2)
where the s quadrature nodes  and  are chosen with respect to the mode of the integrand 
and are scaled according to the estimated curvature at the mode, and weights  and  are 
utilized as defined in Section 1 of the Supplementary Material [Hartzel, Agresti and Caffo 
(2001), Rashid, Sun and Ibrahim (2016)]. Here  and 
. Adaptive quadrature approaches are typically utilized to 
increase the accuracy of an integral approximation while utilizing fewer quadrature points to 
control computational cost. Details regarding the adaptive quadrature procedure are given in 
the Supplementary Material. For all simulations and real data analyses in this manuscript we 
have used s = 10 quadrature points.
The log likelihood corresponding to all n samples can then be expressed as
The derivatives of this log likelihood can be factored into the form of (2.2), and thus 
maximization with respect to the parameters βR,βC, bR, bC,σR,σC and ρ1 can be performed 
via quasi-newton methods such as L-BFGS-B. We provide further details of the 
maximization procedure in the Supplementary Material.
2.2. Bivariate Binomial-logistic-normal regression for Allele-specific Read Counts (ASReC)
Next we consider the statistical model for allele-specific read counts (ASReC). Similar to 
the previous section, we wish to assess conditional correlations after accounting for genetic 
effects. As before, we drop the subject subscript i for notational simplicity and describe the 
PMF for a single sample. For a gene of interest, we assume its two haplotypes are known, 
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and denote them by h1 and h2, respectively. Let NR1 and NR2 be the number of allele-
specific RNA-seq reads from haplotype h1 and h2, respectively, and let NR = NR1 +NR2. 
Analogously, we define NC1, NC2 and NC for the DNase-seq data. We exclude those samples 
with NC < u or NR < u for ASReC studies because allelic imbalance cannot be reliably 
estimated when there are few allele-specific reads. In the following real data studies, we set 
u = 1. For the remaining samples, we model the joint distribution of NR1 and NC1 by a 
Bivariate Binomial-Logistic-Normal regression model (BBLN), denoted by fBBLN:
where fB(;N,π) denotes the binomial distribution probability mass function with N trials and 
probability of success π. In this scenario, success pertains to a read’s alignment to haplotype 
h1. We define πR and πC to be the success probabilities in the RNA-seq and DNase-seq 
data, respectively, given some possible underlying genetic effect. We model πR and πC such 
that log[πR/(1 − πR)] = vRER + ξR and log[πC/(1−πC)] = vCEC +ξC, where ER or EC 
describes the allele-specific effect of a SNP:
that is, the success probability in each data type may be related to an allele-specific effect of 
an underlying SNP. When the SNP is homozygous, it has the same allele in both haplotypes, 
and thus cannot lead to any allelic imbalance of gene expression. Therefore, ER (or EC) = 0 
if the SNP is homozygous. When the SNP is heterozygous and it is responsible for allelic 
imbalance of gene expression, the higher expression haplotype may have either reference 
allele or alternative allele. The magnitude of this effect in each data type is conveyed by vR 
and vC. Thus, the definition of genetic effect relies on which haplotype has the reference 
allele. The confounding covariates XR or XC used for TReC model are ignored because such 
covariates’ effects are often canceled out when we compare the expression of one allele vs. 
the other allele. It is straightforward to add such effects back into the model if needed. 
Similarly to the model for TReC data, we assume ξC and ξR follow a bivariate normal 
distribution: ϕ(ξC, ξR; Σ2) ~ (0,Σ2), where
and −1 ≤ ρ2 ≤ 1 is the correlation parameter. Therefore, in the absence of a shared genetic 
effect, the dependence between the observed allele-specific read counts (NR1 and NC1) is 
induced by the correlation parameter ρ2 between ξC and ξR. We compare and contrast our 
model with that of a generalized mixed linear model framework with heterogeneous 
variances in the discussion section of this paper.
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Finally, the joint log likelihood of ASReC for n individuals is
where I ( ) is an indicator function. We obtain the MLE (Maximum Likelihood Estimate) of 
the parameters similarly to the BPLN model for TReC data; see the Supplementary Material 
for details.
2.3. Testing framework using TReC or ASReC
Utilizing the MLE of the above models, we employ likelihood ratio tests (LRTs) with degree 
of freedom 1 to assess the correlation between gene expression and DHS site. Specifically, 
we will conduct the following four tests:
1. Assess the correlation between RNA-seq and DNase-seq TReC in the presence 
of genetic effects. Conduct the LRT using the TReC likelihood with H0: ρ1 = 0 
vs. H1: ρ1 ≠ 0.
2. Assess the correlation between RNA-seq and DNase-seq TReC in the absence of 
genetic effects. Conduct the LRT using the TReC likelihood with H0: bR = bC = 
ρ1 = 0 vs. H1: bR = bC = 0, and ρ1 ≠ 0.
3. Assess the correlation between RNA-seq and DNase-seq ASReC in the presence 
of genetic effects. Conduct the LRT using the ASReC likelihood with H0: ρ2 = 0 
vs. H1: ρ2 ≠ 0.
4. Assess the correlation between RNA-seq and DNase-seq ASReC in the absence 
of genetic effects. Conduct the LRT using the ASReC likelihood H0: vR = vC = 
ρ2 = 0 vs. H1: vR = vC = 0, and ρ2 ≠ 0.
It is also desirable to test the two null hypotheses ρ1 = 0 and ρ2 = 0 simultaneously as a two 
degree of freedom test. However, it is possible that only one of the null hypotheses is correct 
in certain situations. For example, if the association between gene expression and DHS is 
totally due to a common cis-acting SNP (i.e., ZC = ZR) and the SNP is heterozygous across 
all individuals, then without conditioning on SNP genotype, ρ1 = 0 but ρ2 ≠ 0.
We conduct a genome-wide assessment of the dependency between gene expression and 
DHS in the following steps. First, for each gene, we only consider the DHSs that are local 
(e.g., within 2 kb) since distant DHSs are unlikely to influence gene expression and would 
increase the burden of multiple testing correction. Second, for each gene and each DHS, we 
only consider the SNPs that are close to either feature (e.g., within 2kb of either feature), 
which has been a common practice in previous eQTL studies [Sun (2012)]. Our method 
allows distinct SNPs to be associated with the RNA-seq and DNase-seq data, respectively. 
However, since our focus is to account for the case where the dependence between gene 
expression and DHS is induced by shared genetic effect, we choose to use the same SNP for 
RNA-seq and DNase-seq data (i.e., ZR = ZC). Another important motivation for this strategy 
is to reduce the multiple testing burden. For example, if there are 100 SNPs around a gene-
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DHS pair, we correct for the multiple tests across 100 SNPs in the case of a common SNP 
effect ZR = ZC. However, if we allow two distinct SNPs to be associated with the RNA-seq 
and DNase-seq data (ZR ≠ ZC), 10,000 SNP combinations will be evaluated, with much 
higher multiple testing burden and more complicated correlation structures among the 
10,000 tests. We note that a SNP that is found to explain the correlation between two data 
types may not be the only possible SNP to do so, as we do not survey every single SNP in 
the genome for association. Furthermore, it is possible that two separate SNPs may jointly 
explain such correlation. However, given previous interest in searching for common SNPs 
with a joint effect [Degner et al. (2012)], we focus the rest of the manuscript assuming a 
joing SNP effect.
3. Results
3.1. Simulation studies
We use simulated data to evaluate the power and type I error of the tests in Section 2.3 for a 
triplet of gene expression, DHS and SNP. First, TReC data were simulated from fBPLN 
under the combinations of the following situations:
• Sample size: n = 50, 100 or 300.
• SNP minor allele frequency: 0.5.
• SNP effect: bR = bC = 0, 0.05, 0.075, 0.1, 0.15 or 0.2.
• Four covariates. The first one is the intercept, the other three are simulated from 
uniform (0, 1) distribution. The coefficients are βC = (2.5, 0.5, 0.5, 0.5) and βR = 
(2.5, 1, 1, 1).
•
Variance: , with ρ1 = 0, 0.05, 0.1, 0.15, 0.2, 0.25, 0.35 or 
0.5.
The simulation study results are summarized in Figure 1. We note that bR and bC represent 
the effect of the common SNP on read counts in each data type, whereby larger values of 
each induce more correlation in read counts. Therefore, if one accounts for the SNP effect in 
the BPLN model, the estimated correlation parameter will be much smaller in this model 
relative to the model that ignores the SNP effect. For testing ρ1 = 0 in the presence of a 
shared genetic effect (Figure 1A), there is slight inflation of Type I error for small sample 
sizes (n = 50); however, such inflation disappears as sample size increases (n = 100 or 300). 
When shared genetic effects on RNA-seq and DNase-seq are ignored, testing the correlation 
between RNA-seq and DNase-seq TReC data has inflated Type I error, and such inflation 
increases as the genetic effects bR and bC increase (Figure 1B). This suggests the importance 
of accounting for genetic effects in our model, as the correlation between TReC counts may 
be induced by a shared genetic effect. We also find that the power for detecting the 
correlation between RNA-seq and DNase-seq increases greatly with sample size (Figure 
1C). When the sample size is 50, we achieve approximately 80% power to detect correlation 
ρ1 = 0.5. For n = 300, we achieve 80% power to detect correlation ρ1 = 0.2. The power 
calculations in Figure 1C correspond to data simulated such that bR = bC = 0, while results 
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for other values of bR and bC are similar. Reducing the MAF in our model from 0.5 to 0.1, 
we find that our power analysis with respect to ρ1 is unchanged, as we utilize data from all 
subjects regardless of genotype to estimate ρ1 (Supplementary Figure S1A).
Next, we simulated ASReC data from fBBLN(NRi1,NCi1) over the following situations:
• Sample size: n=50 or 100.
• SNP minor allele frequency: 0.5.
• SNP effect: vR = vC = 0, 0.2, 0.3 or 0.4.
• NR,NC ~ Poisson(λ), λ = 5, 20 or 100.
•
Variance: , where ρ2 = 0, 0.05, 0.1, 0.15, 0.2, 0.25, 
0.035 and 0.5.
The simulation results are shown in Figure 2. When we account for the shared genetic effect, 
testing for ρ2 = 0 has little inflation of Type I error, regardless of the values of π1 and π2 or 
the total number of allele-specific reads (Figures 2A–B). Under model misspecification 
where we ignore genetic effects (i.e., assuming vR = 0 and vC = 0 or, equivalently, πRi = πCi 
= 0.5), type I error in testing for ρ2 = 0 increases as πR and πC deviate from 0.5 (Figures 
2C–D). In Figures 2E–F, we find that the power for testing for ρ2 = 0 is mostly a function of 
the total number of allele-specific reads, while sample size has little effect on power. For 
example, doubling the sample size from n = 50 to n = 100 leads only to modest gains in 
power, mostly at lower levels of ρ2. Notably, having only 5 total allele-specific reads per site 
has almost zero power to detect correlation. This observation justifies our suggestion of 
ignoring allele-specific read data when there are few allele-specific reads. Similar to the 
BPLN simulation, decreasing MAF to 0.1 does not have a large impact on our power to 
detect ρ2 (Supplementary Figure S1B).
3.2. Real data analysis
We applied our method to study the DNase-seq and RNA-seq data of 60 HapMap YRI 
individuals [Degner et al. (2012), Pickrell et al. (2010)]. The data were downloaded from 
http://eqtl.uchicago.edu/. Given the results in simulation studies with respect to model 
misspecification, we seek to assess gene-DHS association in the presence of a common SNP 
effect.
3.2.1. Genotype data preparation—Among these 60 individuals, 42 have phased 
genotypes from the 1000 Genomes Project (TGP) Phase I Release Version 3 [1000 Genomes 
Project Consortium et al. (2012)] consisting of 36 million SNPs. For the remaining 18 
individuals we obtained their corresponding HapMap r27 genotypes consisting of 
approximately 3 million SNPs, and imputed the genotypes and haplotypes on TGP SNPs 
using MACH 1.0 [Li et al. (2010)] with the TGP AFR (African population) reference panel. 
Prior to imputation, about 4000 HapMap SNPs whose rsIDs have changed between human 
genome build hg18 and hg19 were removed using the liftRsNumber tool (http://
genome.sph.umich.edu/wiki/LiftRsNumber.py).
Rashid et al. Page 8
Ann Appl Stat. Author manuscript; available in PMC 2017 October 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
3.2.2. Tabulating TReC for RNA-seq and DNase-seq data—Raw data of paired-end 
RNA-seq reads were downloaded from http://eqtl.uchicago.edu/RNA_Seq_data/
unmapped_reads/ and were mapped to human genome build hg19 using Tophat version 2.0.6 
[Trapnell, Pachter and Salzberg (2009)] given Ensembl transcriptome annotation (GRCh37 
release 66). All lanes of data pertaining to the same individual were merged subsequent to 
mapping.
We obtained the RNA-seq TReC for each gene by first counting the number of RNA-seq 
reads that overlap with exonic regions using R function countReads in R package R/
isoform (http://research.fhcrc.org/sun/en/software/isoform.html) [Sun et al. (2014)]. To 
account for possible batch effects in the RNA-seq TReC data, we computed and retained the 
first 6 principal components from the TReC data matrix for later association analysis using 
TReC data. Specifically, the count data was first transformed such that 
, where yij is the original count for sample i, i = 1 … n and 
feature j, j = 1 … P. P is the total number of features and n is the total number of samples. 
Mapped single-end DNase-seq reads were downloaded from http://eqtl.uchicago.edu/
dsQTL_data/MAPPED_READS/ and were lifted over from build hg18 to hg19 to preserve 
the quality controls performed in a previous study [Degner et al. (2012)]. Total DNase-seq 
read counts were tabulated using BedTools v2.17 [Quinlan and Hall (2010)] for each of 1.5 
million 100 bp candidate regions defined in Degner et al. (2012); and following Degner et al. 
(2012), we assigned a read to a candidate region based on the 5′ start position of each read. 
We also computed and retained the first 6 principal components from the DNase-seq TReC 
data matrix and used them as part of the association analysis using TReC data.
The allele-specific reads mapped to haplotype 1 and haplotype 2 in the RNA-seq data were 
extracted given the list of heterozygous SNPs per individual using R function 
extractAsReads in R package R/asSeq (http://research.fhcrc.org/sun/en/software/
asSeq.html) [Sun (2012)]. The isolation of allele-specific DNase-seq reads was performed 
using the function asCountsBED5 from the R package developed for this manuscript 
BASeG. Then the Allele-specific Read Count (ASReC) per gene and per haplotype was 
counted using R function countReads. As mentioned earlier, adjusting for confounding 
factors is often not necessary in the allele-specific analysis since the ASReC from one 
haplotype is directly compared to the other haplotype within an individual, serving as its 
own control, and thus we do not use any covariate other than genotype for association 
analysis using ASReC data. Other packages for TReC and ASReC read count tabulation 
may be utilized, as our method will accept any n × p table of counts as input for each data 
type, where n is the number of samples and p is the number of features being considered for 
a particular data type.
We performed some additional filtering before our analysis. We removed genes and DNase-
seq candidate regions without enough TReC or ASReC. Specifically, we kept features for 
our allele-specific analysis that had ≥10 allele-specific reads in at least 10 individuals. For 
our TReC-based analysis, we kept genes that had an FPKM (Fragments Per Kilobase of 
sequence Per Million total reads) ≥ 3 in at least 15 individuals and DHSs with RPM (Reads 
Per Million total reads) ≥ 3 in at least 15 individuals, where total sequencing read depth was 
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the sum of number of reads across all sites in an individual. We also removed SNPs with 
minor allele frequency (MAF) less than 0.05. During testing, a Gene-DHS pair was skipped 
if less than 10 individuals had at least 10 allele-specific reads for either type of the data. The 
final number of features utilized for testing in each data type and for each chromosome is 
given in Supplementary Tables S1 and S2 in the Supplementary Material. We only 
performed testing between genes and DHS candidate regions (DHS for short) that are within 
2 Kb of each other, and only consider SNPs that are within 2 Kb of either feature. Using 
TReC data, we tested 9368 gene-DHS pairs (consisting of 2841 genes and 8689 DHSs), with 
9.97 SNPs per gene-DHS pair on average. After removing results from gene-DHS-SNP trios 
that failed during testing (approximately 14%), we are left with 8689 gene-DHS pairs.
We summarized the results for each gene-DHS pair by three p-values:
• puncond: the p-value without conditioning on any SNP.
• pmax: the maximum of the p-values conditioning on each of the local SNPs.
• pmin.corr: the minimum of the p-values conditioning on each of the local 
SNPs, after multiple testing correction.
Suppose Mk local SNPs are considered as possible genetic factors of the kth gene-DHS pair, 
and denote the p-values conditioning on each of these SNPs by (ϱ1, …, ϱMk ). Then 
pmin.corr = min(1, min(ϱ1, …, ϱMk)Mk,eff), where Mk,eff is the effective number of 
independent SNPs of the Mk SNPs [Nyholt (2004)]:
and var(λobs) is the variance of the observed eigenvalues from the correlation matrix of the 
Mk SNPs. A precise correction for multiple testing correction for pmax can be conducted as 
follows. First we can assume the p-values of the Mk SNPs follow a mixture distribution: 
π0f0 + (1 − π0)f1, where f0 is a distribution skewed to 0 and f1 is a uniform distribution. 
Then we need to calculate the effective number of independent SNPs among those SNPs 
whose p-values follow uniform distribution. Denote this number as . Then the multiple 
testing corrected p-value is . The rationale of this formula is as follows. Suppose we 
have  independent p-values, denoted by , which follow the Uniform 
distribution, then . Due to limited SNPs 
around a gene-DHS pair and their strong correlation, it is difficult to estimate , and 
thus we use a conservative choice of .
These three p-values are further converted to q-values using the R package qvalue [Dabney 
and Storey (2015)] to account for multiple testing across the gene-DHS pairs, and we denote 
the q-values by quncond, qmax and qmin.corr, respectively. As illustrated in Figure 3, the 
significant unconditional association of many gene-DHS pairs disappears after conditioning 
one of the local SNPs. The tables in Figure 3C provide a summary in terms of number of 
significant findings at q-value cutoff 0.1. Our method detects significant unconditional 
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associations for 80 gene-DHS pairs (0.92% of pairs), while only 10 of them remain 
significant after conditioning on local SNPs. A previous study testing for correlation 
between RNA-seq and DNase-seq data in this dataset found ~0.7% of all gene-DHS pairs 
tested (3587 out of 4,678,275 pairs) showed significant correlation, after scaling the TReC 
for each data type to account for possible confounding factors [Degner et al. (2012)]. The 
small proportion of gene-DHS pairs with significant unconditional association can be 
explained by the small sample size and low read depth, and thus low statistical power of this 
dataset. We estimated that about 8.1% of gene-DHS pairs are associated without 
conditioning on local SNPs by estimating the non-null proportion of the p-values across all 
the gene-DHS pairs [Dabney and Storey (2015)].
We further examine several significant associations between RNA-seq and DNase-Seq while 
accounting for the effect of a common SNP. In this context, adjusted TReC refers to the 
residuals that are calculated from the BBLN model from each data type. For example, for 
the RNA-seq data, the adjusted TReC is determined as TR −exp(XRβ̂R), where TR is the 
RNA-seq read count for a particular gene, XR is the associated covariate matrix of factors 
for the model that was fit, and β̂R is the estimate for the regression coefficients pertaining to 
the RNA-seq data from the fitted BBLN model. We similarly calculate the residuals for the 
DNase-seq data.
One example involves the RNA-seq TReC of SLFN5 and the DNase-seq TReC of a DHS 
site near an intron approximately 1.5 kb from its transcription start site. SLFN5 has been 
shown to play a role in melanoma and renal cell carcinoma, and is known to be inducible by 
interferon-α [Mavrommatis et al. (2013)]. Ignoring any possible joint SNP effect, we find 
that the correlation between the DNase-seq TReC and SLFN5 RNA-seq TReC is significant 
(Figure 4A, quncond = 5.9 × 10−10). However, after adjusting for the additive genetic 
effects, such as nearby SNP rs11080327 (Figure 4C), we find this correlation is no longer 
significant (Figure 4E, qmax = 1.0), indicating that the observed correlation between the 
RNA-seq TReC and DNase-seq TReC is induced by shared genetic factors. We also observe 
a significant correlation between the RNA-seq TReC from gene EGR1 and the DNase-seq 
TReC for a DHS located upstream of the gene (Figure 4B, quncond = 7.3×10−3). This 
correlation remains significant after adjusting for nearby SNPs, for example, rs7735367 
(Figure 4D, F, qmax = 0.084). In fact, both RNA-seq and DNase-seq data show very weak 
associations with the genotype of rs7735367 (Figure 4D). We also reran our analysis without 
PCs and, after p-value correction, we found that there were approximately 50% fewer 
significant results after our p-value correction compared to when the PCs were utilized.
We also compared our method to the much simpler approach of computing correlations 
between the TReC observed in each of the gene-DHS pairs considered by our model. To 
adjust for read depth, we transformed the TReC from each data type to Counts Per Million 
(CPM). DNase-seq CPM was computed such that the DHS TReC for a given individual was 
divided by the total DNAse-seq read count for that individual, multiplied by one million. 
RNA-seq CPM for a given individual was computed similarly. We then computed three 
types of correlations based on the computed CPMs for each of the gene-DHS pairs 
considered by our model: Spearman correlation between the RNA-seq and DNase-seq CPM, 
Pearson correlation between log(CPM + 1) transformed RNA-seq and DNase-seq CPM, and 
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 transformed RNA-seq and DNase-seq CPM. We then perform a correlation test 
between the CPM from each data type to assess the significance of the association, and p-
values across the gene-DHS pairs were converted to q-values. The results are given in 
Supplementary Figure S3, where we observed 8 significantly associated gene-DHS pairs 
using Spearman correlation, 14 for the Pearson correlation of log(CPM + 1) transformed 
counts and 8 for Pearson correlation of  transformed counts at an FDR threshold of 
0.1. We attribute the lower sensitivity of the simple approach relative to our BBLN model to 
loss of power due to transformation, and also the inability to account for additional possible 
confounders affecting the data.
For our ASReC data, we did not observe many significant results after applying our p-value 
correction procedure (Supplementary Table S3). This is due to the fact that we could not find 
many sites with coverage in both alleles at sufficient depth (Supplementary Figure S2), 
leading to only 567 DHS-gene pairs being evaluated. Of those evaluated, there was a median 
of 17 allele-specific read counts for the DNase-seq data and 46 for the RNA-seq data. This 
also resulted in few individuals being utilized during testing for a given site, as many 
samples did not have enough ASReC in both data types to be included in the model. As the 
cost of high throughput sequencing drops, we expect this to be less of an issue in the near 
future.
4. Discussion
We introduce a new method to model relationships across three types of data: gene 
expression, epigenetic features and genetic variants. We demonstrate the utility and power of 
our method to test for bivariate correlation between RNA-seq and DNase-seq data while 
adjusting for a possible shared genetic effect. Our simulation results show that there is 
relatively low power to detect weaker associations at smaller sample sizes, such as n = 50, 
which may explain the limited number of findings from our real data study with sample size 
60. While this is a limitation for this dataset, in the near future we expect to see larger 
sample sizes as the cost of sequencing decreases.
The univariate form of our model, the Poisson-Log-Normal model, has been long utilized as 
a model to handle overdispersed counts and has been applied in the contexts of species 
abundance analysis [Bulmer (1974)], prediction of highway crash counts [Ma, Kockelman 
and Damien (2008)] and many others. For the TReC data, our BPLN model is a bivariate 
generalization of the Poisson Log-Normal model and a special case of the multivariate 
version introduced by Aitchison and Ho (1989). These methods have similarly been applied 
to contexts involving multivariate overdispersed count data, such as multivariate crash count 
data [Park and Lord (2007)] and network inference in microRNA-seq interaction networks 
[Gallopin et al. (2013)]. The advantage of this approach is the flexibility in specifying the 
correlation structure between the bivariate counts via Σ1. In addition, overdispersion in the 
RNA-seq and DNase-seq TReC is modeled via variances σR and σC, respectively, where 
larger variance corresponds to larger overdispersion. Most importantly, both positive and 
negative correlations are allowed between the bivariate counts using this approach. However, 
the numerical integration that is required to evaluate the BPLN likelihood and derivatives 
increases the complexity of the estimation procedure, and may become unstable for lower 
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sample sizes and lower signal levels. The BBLN (Bivariate Binomial-Logistic-Normal) 
model for the ASReC data also shares similar flexibilities and computational issues as the 
BPLN model.
One alternative to the BPLN is the bivariate negative binomial distribution introduced by 
Famoye (2010). This model is simply the product of two marginal negative binomial 
distributions corresponding to each of the two random variables, plus a multiplicative term 
with an additional parameter λ controlling the correlation of the two random variables. This 
approach also allows for either positive or negative correlations between the two variables, 
and evaluation of the likelihood and derivatives of this distribution does not require 
numerical integration. However, the maximization of the corresponding likelihood with 
respect to λ is difficult in practice because the plausible values of λ are bounded and such 
bounds are not known a priori. When the mean of each marginal distribution is not modeled 
by covariates, these bounds can be derived analytically. However, in the regression setting 
such bounds are difficult to determine. For ASReC, a model analogous to the bivariate 
negative binomial distribution is the Bivariate Beta Binomial Distribution [Danaher and 
Hardie (2005)] and it suffers from similar problems. Our model also shares some similarities 
with the generalized linear mixed model framework with heterogeneous variances. However, 
we do not share any fixed effects covariates or intercepts between data types, complicating 
the specification of the model; that is, each data type has distinct sets of covariates and 
dynamic ranges of signal (TReC for genes are typically larger than TReC for short windows 
tabulating DNA-seq TReC).
Despite the computational complexity of the BPLN and BBLN models, our implementation 
proved to be robust and computationally efficient relative to alternative approaches of 
numerical integration (ns2 operations per likelihood evaluations, where s is the number of 
quadrature points). Our software implementation is freely available as an R package 
accessible at https://github.com/naimrashid/BASeG. In our implementation, testing of 874 
trios in chromosome 21 took 1.5 hours. This time can be greatly reduced by setting more 
lenient convergence criteria, however, we chose more stringent settings for this particular 
study. Sampling-based integration methods such as Monte Carlo integration could have been 
used to evaluate the BPLN and BBLN, however, the inherent randomness in such 
approaches may pose problems during maximization. Fully Bayesian approaches are not 
computationally efficient for our applications.
Given the size of the observed read counts, especially for the RNA-seq data, a logarithmic 
transformation would be merited, and simple correlations can be computed. However, for 
certain features, such as the DHS sites that we consider in our manuscript, such a 
transformation may not be appropriate, as these sites accumulate relatively smaller counts. 
Features such as DHS sites, which are on the order of 100 bp in our manuscript, naturally 
tend to capture relatively fewer sequencing reads relative to larger features like gene bodies. 
In addition, shorter genes may exhibit smaller counts relative to larger genes. More 
importantly, a logarithmic transformation with our BPLN model would be efficient only if 
we are modeling total read counts, not allele-specific read counts, which tend to be much 
lower. For these reasons, we chose to develop a general model that utilizes the count data 
directly instead of modeling the data independent of any transformations.
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Our current model conditions the distribution of the observed read counts in each data type 
jointly on a common SNP, implying that the SNP impacts both gene expression and DNAse-
I hypersensitivity; that is, we are assessing the following causal model: DHS signal 
←SNP→Gene expression. If the causal model is instead SNP→DHS signal→Gene 
expression, we would still observe association between DHS and expression. Conditioning 
on the common SNP in this scenario may reduce our power to detect correlation between 
data types, but would allow for the detection of a direct instead of indirect relation between 
DHS signal and gene expression. One may further compare this conditional independence 
model DHS signal ← SNP → Gene expression versus the following two causal models 
SNP → DHS signal → Gene expression or SNP → Gene expression → DHS signal. 
These tasks can be accomplished by simply comparing the likelihoods of these models or by 
a non-nested likelihood ratio test [Sun, Yu and Li (2007)]. Our approach provides the 
likelihood model for such a comparison, though we did not further make such comparisons 
due to limitations of the real data, for example, sample size and read depth.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Simulation results for the BPLN (Bi-variate Poisson Log Normal) model. (A) Type I error in 
testing for ρ1 = 0 given bC and bR. (B) Type I error in testing for ρ1 = 0 under the 
assumption of bC = 0 and bR = 0 while the true values of bC and bR vary from 0 to 0.2. (C) 
Power in testing for ρ1 = 0 with different sample sizes, given bC = 0 and bR = 0.
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Fig. 2. 
Simulation results for BBLN (Bi-variate Binomial Logistic Normal) model. (A) and (B): 
Type I error in testing for ρ2 = 0 while accounting for genetic effects when n = 50 (A) or n = 
100 (B). (C) and (D): Type I error in testing for ρ2 = 0 while ignoring genetic effect (i.e., 
assuming π1 = 0.5 and π2 = 0.5) when n = 50 (C) or n = 100 (D). (E) and (F): Power in 
testing for ρ2 = 0 when n = 50 (E) or n = 100 (F).
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Fig. 3. 
Panels (A) and (B) show the comparison between unconditional q-value (quncond) vs. (A) 
maximum (conditional) q-value (qmax) and (B) multiple testing corrected minimum 
(conditional) q-value (qmin.corr). Note that multiple testing corrected minimum p-value 
pmin.corr account for multiple testing across multiple SNPs of each gene-DHS pair, while 
calculation of q-value from p-values accounts for multiple testing across multiple gene-DHS 
pairs. The size of each point represents the number of conditioning SNPs for each gene-DHS 
pair, and it is truncated at 10. The dashed lines indicate q-value threshold 0.1 and the solid 
line is the diagonal line of y = x. Panel (C) demonstrates our findings by tables.
Rashid et al. Page 18
Ann Appl Stat. Author manuscript; available in PMC 2017 October 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 4. 
Illustrations of significant interactions between the TReC of select gene-DHS pairs, as well 
as the modulatory effects of nearby SNPs. In this context, adjusted TReC refers to the 
residuals that are calculated from the BBLN model from each data type. (A) Association 
between the adjusted TReC of SLFN5 expression and a DHS in intron 1 of SLF5, and (B) 
the adjusted TReC of EGR1 expression and a DHS in the upstream region of EGR1, after 
accounting for sequencing depth and PCs in the BBLN model. (C) The genotype of SNP 
rs11080327 is associated with both the SLFN5 gene expression and the nearby DHS. (D) 
The genotype of SNP rs7735367 is weakly associated with both the EGR1 gene expression 
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and a nearby DHS. (E) The adjusted TReC of the SLFN5 expression and the nearby DHS is 
not associated after accounting for sequencing depth, PCs and SNP effect of rs11080327 in 
the BBLN model. (F) The adjusted TReC of the EGR1 expression and the nearby DHS are 
still associated after adjusting for sequencing depth, PCs and SNP effect of rs11080327.
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